Reaction Details Report a problem with these data
Target
D(3) dopamine receptor
Ligand
BDBM476855
Substrate
n/a
Meas. Tech.
Binding Assay
Ki
0.150±n/a nM
Citation
 Tobinaga, H; Masuda, K; Inagaki, M; Yonehara, M; Masuda, M Nitrogen-containing condensed ring compounds having dopamine D3 antagonistic effect US Patent  US10870660 Publication Date 12/22/2020 
Target
Name:
D(3) dopamine receptor
Synonyms:
DOPAMINE D3 | DRD3 | DRD3_HUMAN | Dopamine D3 receptor | Dopamine D3 receptor (D3) | Dopamine D3 receptor (D3R) | Dopamine receptor | Dopamine receptor (D3) | Dopamine receptor D3
Type:
n/a
Mol. Mass.:
44243.43
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
400
Sequence:
MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC
  
Inhibitor
Name:
BDBM476855
Synonyms:
US10870660, Compound III-701 | US11345716, Compound III-701
Type:
Small organic molecule
Emp. Form.:
C28H35F3N4O2S
Mol. Mass.:
548.663
SMILES:
CCN1Cc2c(cccc2C(=O)N[C@H]2CC[C@H](CCN3CCc4sc(CCC(F)(F)F)nc4C3)CC2)C1=O |r,wU:16.17,wD:13.13,(13.28,-2.23,;11.74,-2.23,;10.97,-.9,;9.44,-.74,;9.12,.77,;10.45,1.54,;10.45,3.08,;9.12,3.85,;7.78,3.08,;7.78,1.54,;6.45,.77,;6.45,-.77,;5.12,1.54,;3.78,.77,;2.47,1.54,;1.13,.77,;1.13,-.77,;-.2,-1.54,;-1.54,-.77,;-2.87,-1.54,;-2.85,-3.08,;-4.19,-3.85,;-5.52,-3.08,;-6.98,-3.56,;-7.89,-2.31,;-9.43,-2.31,;-10.2,-.98,;-11.74,-.98,;-12.51,.36,;-12.51,-2.31,;-13.28,-.98,;-6.98,-1.06,;-5.52,-1.54,;-4.19,-.77,;2.47,-1.54,;3.8,-.77,;11.6,.51,;13.08,.91,)|
Structure:
Search PDB for entries with ligand similarity: